Get started
Award

201393

Funded outputs count: 11
Funder award ID: 201393
OpenAlex ID: G1509997916
High DNA methylation age deceleration defines an aggressive phenotype with immunoexclusion environments in endometrial carcinoma
2023 · Jing Hao, Tiantian Liu, et al. · Frontiers in Immunology · 7
PDF
The cuproptosis-associated 11 gene signature as a predictor for outcomes and response to Bacillus Calmette-Guerin and immune checkpoint inhibitor therapies in bladder carcinoma
2023 · Huiyang Yuan, Yuchen Xiu, et al. · Frontiers in Immunology · 4
PDF
The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response
2023 · Chang Wang, Xin Qin, et al. · Frontiers in Oncology
PDF
TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance
2023 · Tiantian Liu, Shihong Li, et al. · Frontiers in Immunology · 22
PDF
Widespread genomic/molecular alterations of DNA helicases and their clinical/therapeutic implications across human cancer
2022 · Xin Qin, Jing Wang, et al. · Biomedicine & Pharmacotherapy · 7
PDF
Thyroid carcinoma‐featured telomerase activation and telomere maintenance: Biology and translational/clinical significance
2022 · Xiaotian Yuan, Huiyang Yuan, et al. · Clinical and Translational Medicine · 19
PDF
Genomic, epigenomic, and transcriptomic signatures for telomerase complex components: a pan‐cancer analysis
2022 · Jing Wang, Mingkai Dai, et al. · Molecular Oncology · 17
PDF
The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma
2022 · Huiyang Yuan, Xin Qin, et al. · Frontiers in Immunology · 33
PDF
GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma
2022 · Zhiqing Fang, Ning Zhang, et al. · Journal of Experimental & Clinical Cancer Research · 28
Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features
2022 · Xiangling Xing, Ninni Mu, et al. · Cancers · 22
PDF
DNA Methylation Age Drift Is Associated with Poor Outcomes and De-Differentiation in Papillary and Follicular Thyroid Carcinomas
2021 · Tiantian Liu, Jiansheng Wang, et al. · Cancers · 10
PDF
Year
Topic